Relvar Ellipta 92/22 mcg
Relvar Ellipta 92/22 mcg is a medicine authorised by Swissmedic under authorisation number 62969. The authorisation holder is GlaxoSmithKline AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 09 January 2014 and the authorisation is valid without a time limit. ATC code R03AK10 places the medicine in the group Drugs for obstructive airway diseases.
| Authorisation number | 62969 |
|---|---|
| Name | Relvar Ellipta 92/22 mcg |
| Full name | Relvar Ellipta 92/22 mcg, Einzeldosiertes Pulver zur Inhalation |
| Authorisation holder | GlaxoSmithKline AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | R03AK10 |
| First authorisation | 09 January 2014 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Relvar Ellipta 92/22 mcg, Einzeldosiertes Pulver zur Inhalation | B | 09 January 2014 |
| 2 | Relvar Ellipta 184/22 mcg, Einzeldosiertes Pulver zur Inhalation | B | 09 January 2014 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 30 | Einzeldose(n) | R03AK10 | 03.04.3. | B |
| 3 | 3 x 30 | Einzeldose(n) | R03AK10 | 03.04.3. | B |
| 2 | 30 | Einzeldose(n) | R03AK10 | 03.04.3. | B |
| 4 | 3 x 30 | Einzeldose(n) | R03AK10 | 03.04.3. | B |
Scroll the table sideways
Other medicines from this authorisation holder
Frequently asked questions
Is Relvar Ellipta 92/22 mcg authorised in Switzerland?
Yes. Relvar Ellipta 92/22 mcg is authorised by Swissmedic under authorisation number 62969, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Relvar Ellipta 92/22 mcg have?
Relvar Ellipta 92/22 mcg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Relvar Ellipta 92/22 mcg?
The authorisation holder is GlaxoSmithKline AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.